Rapaid Itch Relief Cream

Χώρα: Αυστραλία

Γλώσσα: Αγγλικά

Πηγή: Department of Health (Therapeutic Goods Administration)

Δραστική ουσία:

Melaleuca Oil

Διαθέσιμο από:

Mundipharma Pty Ltd

INN (Διεθνής Όνομα):

Melaleuca Oil

Kατηγορία:

Medicine Listed

Καθεστώς αδειοδότησης:

Listed

Φύλλο οδηγιών χρήσης

SUXAMETHONIUM
CHLORIDE INJECTION
BP
_Suxamethonium Chloride_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some of the
common questions people ask about
Suxamethonium Chloride Injection.
It does not contain all the information
that is known about Suxamethonium
Chloride Injection.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and
benefits. Your doctor will have
weighed the risks of your being given
Suxamethonium Chloride Injection
against the benefits they expect it
will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
BEING GIVEN THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET.
You may need to read it again.
WHAT SUXAMETHONIUM
CHLORIDE INJECTION IS
FOR
Suxamethonium Chloride Injection is
used to stop your muscles moving
during surgery or medical
procedures.
It belongs to a group of medicines
called neuromuscular blockers which
work by stopping messages being
sent from the nerves to the muscles.
Your doctor will have explained why
you will be given Suxamethonium
Chloride Injection.
FOLLOW ALL DIRECTIONS GIVEN TO YOU
BY YOUR DOCTOR CAREFULLY.
They may differ from the
information contained in this leaflet.
Your doctor may prescribe this
medicine for another use. Ask your
doctor if you want more information.
Suxamethonium Chloride Injection is
not addictive.
BEFORE YOU ARE GIVEN
SUXAMETHONIUM
CHLORIDE INJECTION
You may already have been given
Suxamethonium Chloride Injection.
Your doctor will have considered the
situation carefully and decided to use
it. However, if any of the following
applies to you, tell your doctor
immediately.
_WHEN YOU MUST NOT USE IT_
YOU SHOULD NOT BE GIVEN
SUXAMETHONIUM CHLORIDE INJECTION
IF YOU ARE PREGNANT OR
BREASTFEEDING UNLESS YOUR DOCTOR
SAYS SO. ASK YOUR DOCTOR ABOUT THE
RISKS AND BENEFITS INVOLVED.
We do not know if it is safe for you
to be given it while you are pregnant.
It may affect your baby if you are
given it early in pregnancy or in the
last weeks before your baby is due.
Your baby may tak

Αρχείο Π.Χ.Π.

1 of 9
AUSTRALIAN PRODUCT INFORMATION
SUXAMETHONIUM CHLORIDE INJECTION BP
(SUXAMETHONIUM CHLORIDE)
1
NAME OF THE MEDICINE
Suxamethonium chloride.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
2 mL sterile solution of pH 3.0 – 5.0 containing 100 mg of
suxamethonium chloride.
Suxamethonium chloride is a white or almost white, crystalline powder.
Excipient with known effect: sodium hydroxide.
For the full list of excipients, see Section 6.1.
3
PHARMACEUTICAL FORM
Injection solution. Clear, colourless solution.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the production of skeletal muscle relaxation in anaesthesia.
Suited for procedures requiring
only brief relaxation such as endotracheal intubation, endoscopic
examinations, orthopaedic
manipulations, short surgical procedures and electro-convulsive
therapy.
4.2
DOSE AND METHOD OF ADMINISTRATION
Dosage is individualised and its administration should be determined
after careful assessment of the
patient. The dose of suxamethonium is dependent on bodyweight, the
degree of muscle relaxation
required and the response of individual patients. Suxamethonium causes
paralysis of the respiratory
muscles, therefore after administration, respiration must be
controlled. It should not be
administered to a conscious patient.
Suxamethonium should not be mixed with any neuromuscular blocking
agent, nor with general
anaesthetics such as short acting barbiturates, nor any other
therapeutic agent in the same syringe.
Suxamethonium Chloride Injection contains no antimicrobial agent. It
should be used only once
and any residue discarded.
An initial test dose of 0.1 mg/kg may be given intravenously to
determine the patients response.
ADULT
For short procedures, such as endotracheal intubation the usual adult
dose is
0.6 mg/kg (range 0.3 - 1.1 mg/kg) administered IV over 10 to 30
seconds. This dose produces
muscle relaxation in about 60 seconds and has a duration of
approximately 4 to 6 minutes. Larger
doses produce more prolonged muscle relaxation.
2 of 9
For more prolonged surgic